PMID- 35661780 OWN - NLM STAT- MEDLINE DCOM- 20220608 LR - 20220802 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 12 IP - 1 DP - 2022 Jun 3 TI - HLA class II variants defined by next generation sequencing are associated with sarcoidosis in Korean patients. PG - 9302 LID - 10.1038/s41598-022-13199-w [doi] LID - 9302 AB - Polymorphic genes with immune functions, namely those of the human leukocyte antigen (HLA) system, have been implicated in sarcoidosis pathogenesis. As HLA polymorphisms in sarcoidosis have not been yet investigated in the Korean population, we used next-generation sequencing (NGS), allowing detailed characterization of HLA alleles to investigate the role of HLA variation in Korean sarcoidosis patients. We enrolled 103 patients diagnosed by the ATS/ERS/WASOG guidelines at Asan Medical Centre, Seoul, Korea. Among those, genotyping of 7 HLA loci (HLA-A, -B, -C, -DQA1, -DQB1, -DRB1, -DPB1) was performed using Omixon Holotype kit and HLATwin software. HLA allele frequencies were compared with frequency data on healthy Koreans from the allelic frequency databases, and 4-digit characteristics of HLA genotyping were used. Associations were assessed by two-tailed Fischer's exact test with correction for multiple comparisons. Variants previously associated with sarcoidosis risk (HLA-C*03:04, HLA-DRB1*12:01, HLA-DRB1*14:54) and a known protective variant HLA-DPB1*04:01, were associated with sarcoidosis in Koreans. Further, we suggest new HLA variants associated with sarcoidosis risk (e.g., HLA-DQA1*05:08) and novel protective variants HLA-DQB1*03:02 and HLA-DQA1*01:02 in Koreans. This first study of HLA variation in Korean patients with sarcoidosis by precise genotyping methodology reports data that could serve future meta-analyses on HLA variation's role in sarcoidosis. CI - (c) 2022. The Author(s). FAU - Sikorova, Katerina AU - Sikorova K AD - Department of Pathological Physiology & Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic. FAU - Moon, Su-Jin AU - Moon SJ AD - Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. FAU - Yoon, Hee-Young AU - Yoon HY AD - Division of Allergy and Respiratory Diseases, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea. FAU - Strnad, Adam AU - Strnad A AD - Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic. FAU - Song, Jin Woo AU - Song JW AD - Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. jwsongasan@gmail.com. FAU - Petrek, Martin AU - Petrek M AD - Department of Pathological Physiology & Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic. martin.petrek2@fnol.cz. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220603 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (HLA-DRB1 Chains) RN - 0 (Histocompatibility Antigens Class I) SB - IM MH - Alleles MH - Gene Frequency MH - HLA-DRB1 Chains/genetics MH - Haplotypes MH - *High-Throughput Nucleotide Sequencing MH - Histocompatibility Antigens Class I/genetics MH - Humans MH - *Sarcoidosis/genetics PMC - PMC9166778 COIS- The authors declare no competing interests. EDAT- 2022/06/07 06:00 MHDA- 2022/06/09 06:00 PMCR- 2022/06/03 CRDT- 2022/06/06 12:53 PHST- 2022/01/27 00:00 [received] PHST- 2022/05/23 00:00 [accepted] PHST- 2022/06/06 12:53 [entrez] PHST- 2022/06/07 06:00 [pubmed] PHST- 2022/06/09 06:00 [medline] PHST- 2022/06/03 00:00 [pmc-release] AID - 10.1038/s41598-022-13199-w [pii] AID - 13199 [pii] AID - 10.1038/s41598-022-13199-w [doi] PST - epublish SO - Sci Rep. 2022 Jun 3;12(1):9302. doi: 10.1038/s41598-022-13199-w.